Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

October 5-7, 2016
Boston Convention and Exhibition Center,
Boston, MA

The most complete event to successfully blueprint cell, gene, and immunotherapies from proof of concept to commercialization

Join the unique event that brings together 300+ key industry and academic luminaries to collectively discuss strategies and share lessons learned resulting from their latest research data and case studies.

Accelerate Your Cell and Gene-Based products towards commercial success

Navigate the Pathway to Commercialization

Gain insights from 80+ global thought-leading speakers on how overcome today’s challenges involving scale-up, facility design, characterization, tech transfer, regulatory approval, investment, reimbursement and more. New in-depth content added includes:

  • Gene Therapy
  • Immuno-Oncology
  • Regulatory Concerns
Ensure a Successful Product-to-Market Launch

Evaluate leading technologies by meeting face-to-face with 25+ international CMOs, CROs and who can accelerate your product towards commercial success.

Meet the Right Partners to Grow Your Business

Connect with 300+ thought-leaders and service providers who can offer the strategic, technical and financial support to ensure a success cell-based product launch.

What Makes This Event Unique

Six Focused Tracks

Keep your team up to date on the latest science, technologies and industry updates across the entire spectrum of cell therapy, gene therapy, and immuno-oncology product development:

  • NEW! Regulatory Considerations
  • NEW! Immuno-Oncology
  • NEW! Gene Therapy Development & Production
  • Cell Therapy Bioprocessing
  • Tools & Technologies
  • Commercialization
Content For All Company Types

This year’s event presents a complete blueprint from bench to commercial scale that’s accessible for any sized company, including:

  • Mid-Sized Gene and Cell Therapy Companies
  • Biotech Start-Ups 
  • Virtual Companies
  • Large Pharma and Biotechs
  • Academic Institutions
Why People Come Back

"The go-to conference for everything related to Cell Therapy Bioprocessing and Commercialization.Great technology, a comprehensive program, and a wonderful exhibit hall. This conference is a great place to do business.” — Jon Rowley, Rooster Bio

“The only one of its kind.” — Mahendra Rao, NYSCF

“This is a great event to keep abreast of the manufacturing advancements for the rapidly evolving cell and gene therapy industry.” — Brian Hampson, PCT, A Caladrius Company

Commercialization of Cell and Gene Therapies


The global market for cell - based therapies is expected to surpass the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell - based therapies are high impact disease areas with significant unmet needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases.

Present a Scientific Poster at Cell and Gene Therapy 2016


Highlight your company's latest research findings by presenting a scientific poster. The deadline to submit your poster is September 2, 2016.

Plan Your Visit


Boston is a bustling city, but you can cover the center on foot in just a couple of hours. With the history of the Freedom Trail, the modern attractions of the Institute of Contemporary Art and everything in between, Boston is worth exploring for a weekend. For information on the venue, official conference hotel details, transportation, and more click here.

Networking Reception Co-Sponsor